Jiang YZ, Ge LP, Jin X, Fan L, et al. Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations. Breast Cancer Res Treat 2020 Sep 25. pii: 10.1007/s10549-020-05940.
PMID: 32975708